JERUSALEM (VINnews) — Israeli scientists have made an immunotherapy drug effective with just a millionth of its original dose, according to a Technion study. The original drug fell at the last hurdle because regulators were concerned that the large dose could cause severe side effects. However the current technology uses a “Nano-Ghosts” platform, making it […]